The Propell Group

Overview

The Propell Group is a boutique venture investor and advisory firm based in Singapore, specializing in healthtech start-ups and growth companies. They focus on early-stage investments and startup acceleration globally within the healthcare technology sector, investing their own capital in collaboration with high-net-worth individuals, family offices, and institutions on a deal-by-deal basis. The firm provides pragmatic mentorship to startups, supporting them with access to an extensive network of multinationals, investors, and government agencies. In addition to investment activities, The Propell Group offers boutique M&A, licensing, and capital introductions advisory services to healthcare companies, including business strategy advisory to SMEs and larger organizations seeking to deliver innovative commercial solutions, primarily in the Asia Pacific region. Founded by Julien de Salaberry, who has over 15 years of experience in healthcare with leading brands such as Eli Lilly, Boston Scientific, Baxter, GSK, and Merck & Co., The Propell Group leverages his extensive networks and expertise to identify unique ventures and support their growth. Julien is also a co-author of 'iDisrupted,' a book focusing on technological changes reshaping daily lives, and is a regular speaker on healthcare disruption and innovation topics. The Propell Group's investment strategy emphasizes early-stage opportunities in the healthtech sector, aiming to foster innovation and growth in healthcare through strategic investments and advisory services. Their approach combines financial support with strategic guidance, leveraging a broad network to enhance the success of their portfolio companies. The firm's commitment to the Asia Pacific region is evident in its focus on delivering innovative commercial solutions and supporting the growth of healthcare companies within this market. Their track record includes successful investments and advisory engagements that have contributed to the advancement of healthtech startups and the broader healthcare industry.